Santa Rosa’s annual Big Cat Invitational rung in the start of the 2026 track and field season in the North Bay. Local standouts got things off to a roaring start as a handful of meet records were set ...

The 2026 NFL Draft is over a month away, which gives some of the top players in the class a chance to showcase their skillsets one final time at the scouting combine in Indianapolis. Saturday marked ...

This is read by an automated voice. Please report any issues or inconsistencies here. LeBron James breaks Kareem Abdul-Jabbar’s record for most field goals made in the Lakers’ 120-113 loss to the ...

It's now been three months since Elden Ring: Nightreign received its paid Forsaken Hollows DLC, which added two new Nightfarers, a new map, two new end bosses and a bundle of other new bosses, enemies ...

As Oklahomans look toward another round of severe weather Friday night, the state is recovering from deadly storms that hit the region overnight Thursday, March 5. According to the National Weather ...

Saturday’s NFL Combine in Indianapolis provided a showcase for quarterback athleticism, and Taylen Green of Arkansas delivered a performance that left scouts and analysts buzzing. The dual-threat ...

Online Security 3.5 million hit in US college data breach with full names, dates of birth, SSNs, bank info and more exposed — how to see if you’re affected Online Security 22.6 million hit in massive ...

Sanju Samson continued his remarkable run in the ICC Men's T20 World Cup 2026 with another stunning knock in the final, giving India a blazing start with 89 runs off just 45 balls. The wicketkeeper ...

The Pittsburgh Steelers are still waiting on a clear statement from quarterback Aaron Rodgers on his plans for the 2026 NFL season, but according to Ian Rapoport of NFL Network, the team is expecting ...

Khloé Kardashian hasn’t closed the door on having another baby. The reality star explained to “Khloé in Wonderland” podcast listeners Wednesday that she has been “contemplating” welcoming a third ...

A second phase 3 study of Roche’s fenebrutinib in relapsing multiple sclerosis (RMS) has hit its primary endpoint, positioning the company to submit the BTK inhibitor for approval. But the discovery ...